Search

everythinglearnresearchcommunity

for

Search:↓

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Hair thickness differences help diagnose hair loss severity.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

miR-155-5p can help diagnose and track alopecia areata severity.

People with mycosis fungoides/Sézary syndrome have a much lower quality of life.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

The digital system for measuring melasma shows promise but needs more development for better accuracy and automation.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Hair loss may indicate higher risk of heart disease.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Antera 3D® offers more precise and detailed scar assessment than traditional methods.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

The screening method effectively predicts psychosis, valproate use is linked to hair loss, and IDEAS is valid for assessing mental disorder disability.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.